Allogene Therapeutics, Inc. - ALLO

Sector: Healthcare · Industry: Biological Products, (No Diagnostic Substances)

Website: No information yet · Social: No information yet

Company profile

Latest / Compare

Q1 2026 · Q4 2025

Value (USD)

Total reported value ($000)

$462.4M

QoQ value delta ($000)

+$239.3M (+107.3%)

Implied price effect (QoQ)

+71.64%

Total shares

196,775,552

QoQ shares delta

+33,841,213 (+20.77%)

Total shares held by funds (by quarter)

Interactive chart by TradingView.

Top 25 only Full list

Partial Q1 2026 data: 208 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.

Manager	Value ($000)	Shares	% of 13F
PFIZER INC	49,792	22,032,040	20.85%
BlackRock, Inc.	46,582	19,091,095	0.0%
TPG GP A, LLC	45,667	18,716,306	1.24%
STATE STREET CORP	21,131	8,660,306	0.0%
PRIMECAP MANAGEMENT CO/CA/	20,446	8,379,840	0.02%
VANGUARD CAPITAL MANAGEMENT LLC	16,888	6,921,350	0.0%
CITADEL ADVISORS LLC	16,804	6,887,120	0.0%
PRICE T ROWE ASSOCIATES INC /MD/	13,130	5,380,902	0.0%
TWO SIGMA INVESTMENTS, LP	13,116	5,375,456	0.01%
VANGUARD GROUP INC	12,674	9,251,609	0.0%
GEODE CAPITAL MANAGEMENT, LLC	10,065	4,124,178	0.0%
Frazier Life Sciences Management, L.P.	9,263	3,796,668	0.24%
Woodline Partners LP	8,542	3,501,078	0.03%
Patient Square Capital LP	8,418	3,450,000	1.49%
MARSHALL WACE, LLP	8,413	3,447,984	0.01%
MILLENNIUM MANAGEMENT LLC	8,105	3,322,053	0.0%
Candriam S.C.A.	7,313	2,997,318	0.04%
Wildcat Capital Management, LLC	7,126	2,920,787	6.71%
GOLDMAN SACHS GROUP INC	6,749	2,766,244	0.0%
D. E. Shaw & Co., Inc.	6,743	2,763,776	0.0%
Boxer Capital Management, LLC	6,649	2,725,000	0.87%
AQR CAPITAL MANAGEMENT LLC	6,062	2,484,780	0.0%
Nuveen, LLC	5,648	2,315,092	0.0%
MPM BioImpact LLC	5,472	2,242,933	0.42%
RENAISSANCE TECHNOLOGIES LLC	5,219	2,139,328	0.01%